Invention Grant
- Patent Title: Dermatological, pharmaceutical composition suitable for oligonucleotides
- Patent Title (中): 适用于寡核苷酸的皮肤病学药物组合物
-
Application No.: US13578013Application Date: 2011-02-11
-
Publication No.: US09249413B2Publication Date: 2016-02-02
- Inventor: Thomas Schmidts , Holger Garn , Frank Runkel
- Applicant: Thomas Schmidts , Holger Garn , Frank Runkel
- Applicant Address: DE Marburg
- Assignee: STERNA BIOLOGICALS GMBH & CO. KG
- Current Assignee: STERNA BIOLOGICALS GMBH & CO. KG
- Current Assignee Address: DE Marburg
- Agency: Marshall, Gerstein & Borun LLP
- Priority: DE102010007562 20100210
- International Application: PCT/EP2011/000648 WO 20110211
- International Announcement: WO2011/098285 WO 20110818
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C07H21/02 ; C07H21/04 ; C12N15/11 ; C12N15/113 ; A61K9/00 ; A61K9/107 ; A61K9/113
Abstract:
The invention relates to a cosmetic and/or dermatological and/or pharmaceutical composition for the topical use and application of oligonucleotides, in particular antisense-oligonucleotides such as DNAzyme, siRNAs, asDNAs or ribozymes for use as an agent against inflammatory diseases by means of emulsions having a dispersed, internal, discontinuous aqueous phase.
Public/Granted literature
- US20130030038A1 Dermatological, Pharmaceutical Composition Suitable for Oligonucleotides Public/Granted day:2013-01-31
Information query
